The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760 · cited 1×
“E-cadherin mutations in gastric carcinoma [1] (multiple letters).”
BackgroundBang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61121-x · Cited by 7,302
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
Sakuramoto, S., Sasako, M., Yamaguchi, T., Kinoshita, T., Fujii, M., Nashimoto, A., Furukawa, H., Nakajima, T., Ohashi, Y., Imamura, H., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072252 · Cited by 2,517
Assessment of a HER2 scoring system for gastric cancer: results from a validation study
Hofmann, M., Stoss, O., Shi, D., Büttner, R., Van De Vijver, M., Kim, W., Ochiai, A., Rüschoff, J., & Henkel, T. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03028.x · Cited by 1,187
Al-Batran, S.-E., Hartmann, J. T., Probst, S., Schmalenberg, H., Hollerbach, S., Hofheinz, R., Rethwisch, V., Seipelt, G., Homann, N., Wilhelm, G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9378 · Cited by 782
Self-citationDawood, S., Broglio, K., Buzdar, A. U., Hortobagyi, G. N., & Giordano, S. H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9844 · Cited by 758
Tanner, M., Hollmén, M., Junttila, T. T., Kapanen, A. I., Tommola, S., Soini, Y., Helin, H., Salo, J., Joensuu, H., Sihvo, E., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi064 · Cited by 665
Ajani, J. A., Rodriguez, W., Bodoky, G., Moiseyenko, V., Lichinitser, M., Gorbunova, V., Vynnychenko, I., Garin, A., Lang, I., & Falcon, S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.4706 · Cited by 550
Vanhoefer, U., Rougier, P., Wilke, H., Ducreux, M. P., Lacave, A. J., Van Cutsem, E., Planker, M., Santos, J. G. D., Piedbois, P., Paillot, B., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.14.2648 · Cited by 531
Seshadri, R., Firgaira, F. A., Horsfall, D. J., McCaul, K., Setlur, V, & Kitchen, P. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.10.1936 · Cited by 528
Nakajima, M., Sawada, H., Yamada, Y., Watanabe, A., Tatsumi, M., Yamashita, J., Matsuda, M., Sakaguchi, T., Hirao, T., & Nakano, H. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990501)85:9%3c1894::aid-cncr3%3e3.0.co;2-j · Cited by 494
Rüschoff, J., Dietel, M., Baretton, G., Arbogast, S., Walch, A., Monges, G., Chenard, M.-P., Penault-Llorca, F., Nagelmeier, I., Schlake, W., et al. (2010) · Virchows Archiv · doi:10.1007/s00428-010-0952-2 · Cited by 486
Mayer, B., Johnson, J. P., Leitl, F., Jauch, K. W., Heiss, M. M., Schildberg, F. W., Birchmeier, W., & Funke, I. (1993) · PubMed · Cited by 440
Early Gastric Cancer in Young, Asymptomatic Carriers of Germ-Line E-Cadherin Mutations
Huntsman, D. D., Carneiro, F., Lewis, F. R., MacLeod, P., Hayashi, A., Monaghan, K. G., Maung, R., Seruca, R., Jackson, C. E., & Caldas, C. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442504 · Cited by 416
Yonemura, Y., Ninomiya, I., Yamaguchi, A., Fushida, S., Kimura, H., Ohoyama, S., Miyazaki, I., Endou, Y., Tanaka, M., & Sasaki, T. (1991) · PubMed · Cited by 375
HER-2/neu Amplification Is an Independent Prognostic Factor in Gastric Cancer
Park, D. I., Yun, J. W., Park, J. H., Oh, S. J., Kim, H. J., Cho, Y. K., Sohn, C. I., Jeon, W. K., Kim, B. I., Yoo, C. H., et al. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-005-9057-1 · Cited by 329
Allgayer, H., Babic, R., Gruetzner, K. U., Tarabichi, A., Schildberg, F. W., & Heiss, M. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2201 · Cited by 276
Begnami, M. D., Fukuda, E., Fregnani, J. H. T. G., Nonogaki, S., MONTAGNINI, A. L., da Costa, W. L., & Soares, F. A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.6313 · Cited by 272
Grabsch, H., Sivakumar, S., Gray, S., Gabbert, H. E., & Müller, W. (2010) · Analytical Cellular Pathology · doi:10.1155/2010/519498 · Cited by 263
Takehana, T., Kunitomo, K., Kono, K., Kitahara, F., Iizuka, H., Matsumoto, Y., Fujino, M. A., & Ooi, A. (2002) · International Journal of Cancer · doi:10.1002/ijc.10257 · Cited by 195
Shah, M. A., Jhawer, M., Ilson, D. H., Lefkowitz, R. A., Robinson, E., Capanu, M., & Kelsen, D. P. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.0770 · Cited by 186
Self-citationGarc�a, I., Vizoso, F., Mart�n, A., Sanz, L., Abdel-Lah, O., Raigoso, P., & Garc�a-Mu�iz, J. L. (2003) · Annals of Surgical Oncology · doi:10.1245/aso.2003.05.010 · Cited by 177
Gene amplification in gastric and esophageal adenocarcinomas.
Houldsworth, J., Cordon‐Cardo, C., Ladanyi, M., Kelsen, D. P., & Chaganti, R. S. K. (1990) · PubMed · Cited by 156
Self-citationKunz, P. L., Mojtahed, A., Fisher, G. A., Ford, J. M., Chang, D. T., Balise, R. R., Bangs, C. D., Cherry, A. M., & Pai, R. K. (2011) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0b013e31821c821c · Cited by 152
HER 2/neu protein expression in colorectal cancer
Schuell, B., Gruenberger, T., Scheithauer, W., Zielinski, C. C., & Wrba, F. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-123 · Cited by 147
ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix.
Mitra, A., Murty, V. V. V. S., Pratap, M., Sodhani, P., & Chaganti, R. S. K. (1994) · PubMed · Cited by 122
HER-2/neu Oncogene Characterization in Head and Neck Squamous Cell Carcinoma
Beckhardt, R. N., Kiyokawa, N., Li, X., Liu, T.-J., Hung, M., El‐Naggar, A. K., Zhang, H.-Z., & Clayman, G. L. (1995) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1995.01890110041008 · Cited by 91
Double immunostaining for c-erbB-2 and p53 in human stomach cancer cells
Sasano, H., Date, F., Imatani, A., Asaki, S., & Nagura, H. (1993) · Human Pathology · doi:10.1016/0046-8177(93)90236-a · Cited by 83
The prognostic value of serum and immunohistochemical tumour markers in advanced gastric cancer
Webb, A., Scott-Mackie, P., Cunningham, D., et al. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00504-8 · Cited by 72
HER-2/neu Gene Amplification in Esophageal Adenocarcinoma and Its Influence on Survival
Thompson, S. K., Sullivan, T., Davies, R., & Ruszkiewicz, A. R. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-1554-1 · Cited by 60
Cox-2 and Her2/neu co-expression in invasive bladder cancer
Eltze, E., Wülfing, C., von Struensee, D., Piechota, H., Buerger, H., & Hertle, L. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.6.1525 · Cited by 58
Rauser, S., Weis, R., Braselmann, H., Feith, M., Stein, H. J., Langer, R., Hutzler, P., Hausmann, M., Laßmann, S., Siewert, J. R., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0465 · Cited by 47
Cited by
Janjigian, Y. Y., Shitara, K., Moehler, M., Garrido, M., Salman, P., Shen, L., Wyrwicz, L., Yamaguchi, K., Skoczylas, T., Campos Bragagnoli, A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00797-2 · Cited by 3,041
Self-citationGastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Ajani, J. A., D’Amico, T. A., Bentrem, D. J., Chao, J., Cooke, D., Corvera, C., Das, P., Enzinger, P. C., Enzler, T., Fanta, P., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0008 · Cited by 1,684
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Tumour heterogeneity in the clinic
Bedard, P. L., Hansen, A. R., Ratain, M. J., & Siu, L. L. (2013) · Nature · doi:10.1038/nature12627 · Cited by 1,211
Shah, M. A., Shitara, K., Ajani, J. A., Bang, Y.-J., Enzinger, P., Ilson, D., Lordick, F., Van Cutsem, E., Gallego Plazas, J., Huang, J., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02465-7 · Cited by 681
Self-citation
Metadata
- Authors
- Janjigian, Y. Y., Werner, D., Pauligk, C., Steinmetz, K., Kelsen, D. P., Jäger, E., Altmannsberger, H. M., Robinson, E., Tafe, L. J., Tang, L. H., Shah, M. A., & Al-Batran, S.-E.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 23
- Issue
- 10
- Pages
- 2656-2662
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2138993970
- Cited by
- 356
- References
- 33
- FWCI
- 25.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.